Foghorn Therapeutics (FHTX) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free FHTX Stock Alerts $5.83 +0.03 (+0.52%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Foghorn Therapeutics Short Interest DataCurrent Short Interest1,300,000 sharesPrevious Short Interest1,320,000 sharesChange Vs. Previous Month-1.52%Dollar Volume Sold Short$6.88 millionShort Interest Ratio14.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares42,590,000 sharesFloat Size24,320,000 sharesShort Percent of Float5.35%Today's Trading Volume216,234 sharesAverage Trading Volume94,325 sharesToday's Volume Vs. Average229% Short Selling Foghorn Therapeutics ? Sign up to receive the latest short interest report for Foghorn Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFHTX Short Interest Over TimeFHTX Days to Cover Over TimeFHTX Percentage of Float Shorted Over Time Ad Porter & CompanyThe Worst is Yet to Come…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Foghorn Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,300,000 shares $6.88 million -1.5%5.4%14.1 $5.29 4/30/20241,320,000 shares $7.21 million +11.9%7.1%9.6 $5.46 4/15/20241,180,000 shares $7.54 million -0.8%6.3%7.4 $6.39 3/31/20241,190,000 shares $7.98 million -4.8%6.4%7.4 $6.71 3/15/20241,250,000 shares $7.39 million No Change6.8%7.7 $5.91 2/29/20241,250,000 shares $9.66 million -8.8%6.8%7.5 $7.73 Get the Latest News and Ratings for FHTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,370,000 shares $9.33 million +29.3%7.5%8.7 $6.81 1/31/20241,060,000 shares $3.37 million +16.2%6.0%7.7 $3.18 1/15/2024912,600 shares $4.80 million -0.2%5.2%9.5 $5.26 12/31/2023914,200 shares $5.90 million -8.0%5.2%9.2 $6.45 12/15/2023994,100 shares $5.26 million -3.5%5.7%9.4 $5.29 11/30/20231,030,000 shares $4.38 million -1.0%5.9%10.4 $4.25 11/15/20231,040,000 shares $4.17 million -23.5%6.0%10.3 $4.01 10/31/20231,360,000 shares $4.56 million +17.2%7.8%14.7 $3.35 10/15/20231,160,000 shares $4.05 million -28.8%6.7%13.9 $3.49 9/30/20231,630,000 shares $8.15 million -2.4%9.5%20.9 $5.00 9/15/20231,670,000 shares $10.87 million -5.1%9.7%25.5 $6.51 8/31/20231,760,000 shares $13.32 million -15.4%9.8%23.6 $7.57 8/15/20232,080,000 shares $20.53 million No Change11.6%28.6 $9.87 7/31/20232,080,000 shares $19.05 million -3.3%11.8%24.7 $9.16 7/15/20232,150,000 shares $16.77 million +1.4%12.4%23.1 $7.80 6/30/20232,120,000 shares $14.92 million +1.0%12.1%21.5 $7.04 6/15/20232,100,000 shares $17.87 million -0.9%12.0%22.3 $8.51 5/31/20232,120,000 shares $13.33 million -0.9%12.1%24.7 $6.29 5/15/20232,140,000 shares $13.80 million +3.9%12.2%26.7 $6.45 4/30/20232,060,000 shares $13.43 million No Change11.7%27.4 $6.52 4/15/20232,060,000 shares $14.75 million -5.9%11.7%30.7 $7.16 3/31/20232,190,000 shares $13.58 million +3.3%12.5%32.1 $6.20 3/15/20232,120,000 shares $10.41 million +3.9%12.1%31 $4.91 2/28/20232,040,000 shares $11.69 million +3.6%11.6%27.3 $5.73 2/15/20231,970,000 shares $12.27 million +5.9%11.2%24.5 $6.23 1/31/20231,860,000 shares $16.00 million +0.5%10.6%21.8 $8.60 1/15/20231,850,000 shares $16.11 million -2.1%10.6%20.9 $8.71 12/30/20221,890,000 shares $12.06 million +3.3%10.8%23.7 $6.38 12/15/20221,830,000 shares $11.75 million +0.6%10.4%22.9 $6.42 11/30/20221,820,000 shares $12.29 million -6.7%10.4%23.2 $6.75 11/15/20221,950,000 shares $18.00 million -22.6%11.2%24.3 $9.23 10/31/20222,520,000 shares $22.02 million +2.4%14.1%26.9 $8.74 10/15/20222,460,000 shares $18.23 million -0.8%13.8%25.9 $7.41 9/30/20222,480,000 shares $21.28 million +0.8%13.9%25.5 $8.58This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 9/15/20222,460,000 shares $24.43 million +2.1%13.8%23.6 $9.93 8/31/20222,410,000 shares $23.96 million -11.4%13.5%21.7 $9.94 8/15/20222,720,000 shares $45.59 million -4.2%15.2%21.2 $16.76 7/31/20222,840,000 shares $41.55 million -3.7%16.0%19.8 $14.63 7/15/20222,950,000 shares $45.28 million -1.0%16.6%20.6 $15.35 6/30/20222,980,000 shares $40.53 million -0.3%16.8%20.5 $13.60 6/15/20222,990,000 shares $36.75 million +4.2%16.8%19.6 $12.29 5/31/20222,870,000 shares $37.02 million +6.3%16.1%17.5 $12.90 5/15/20222,700,000 shares $27.68 million +38.5%15.1%15.2 $10.25 4/30/20221,950,000 shares $22.60 million -2.0%10.9%13.6 $11.59 4/15/20221,990,000 shares $29.01 million +0.5%11.2%14.2 $14.58 3/31/20221,980,000 shares $30.16 million +3.7%N/A12.7 $15.23 3/15/20221,910,000 shares $21.41 million +76.9%10.7%10.3 $11.21 2/28/20221,080,000 shares $10.38 million +21.6%7.2%1.8 $9.61 2/15/2022888,500 shares $11.11 million +10.8%5.9%1.6 $12.50 1/31/2022802,000 shares $12.33 million -11.3%5.9%1.4 $15.38 1/15/2022904,200 shares $15.92 million -13.1%N/A0 $17.61 12/31/20211,040,000 shares $23.78 million -24.6%7.7%1.9 $22.87 12/15/20211,380,000 shares $24.26 million +97.5%10.2%2.7 $17.58 11/30/2021698,600 shares $8.08 million +2.8%4.1%11.4 $11.57 11/15/2021679,800 shares $9.27 million -10.7%4.0%10.2 $13.63 10/29/2021760,900 shares $9.66 million -10.9%4.5%10.9 $12.69 10/15/2021853,600 shares $10.57 million -1.1%5.0%12.1 $12.38 9/30/2021863,100 shares $12.02 million -1.7%5.1%12.4 $13.93 9/15/2021877,600 shares $11.16 million -3.9%5.1%8.4 $12.72 8/31/2021912,800 shares $11.85 million -6.6%5.4%7.8 $12.98 8/13/2021977,400 shares $9.34 million +3.9%5.7%8.5 $9.56 7/30/2021941,100 shares $8.54 million -0.8%5.5%7.9 $9.07 7/15/2021948,900 shares $8.96 million -1.5%5.6%7.9 $9.44 6/30/2021963,600 shares $10.28 million +17.0%5.7%7.9 $10.67 6/15/2021823,500 shares $9.87 million +11.6%4.8%9.1 $11.99 5/28/2021737,700 shares $7.68 million -1.4%4.3%8.1 $10.41 5/14/2021748,300 shares $7.48 million +2.8%4.4%8.7 $9.99 4/30/2021727,800 shares $7.73 million -1.3%4.3%8.6 $10.62 4/15/2021737,300 shares $8.80 million -0.6%N/A0 $11.94 3/31/2021741,800 shares $9.66 million +24.3%4.3%7.1 $13.02 3/15/2021596,800 shares $7.49 million +5.4%3.6%4.7 $12.55 2/26/2021566,400 shares $9.23 million +9.8%3.5%4.8 $16.30 2/12/2021515,800 shares $8.82 million +25.0%3.2%4 $17.09 1/29/2021412,500 shares $6.86 million +43.2%2.6%2.9 $16.63 1/15/2021288,100 shares $5.47 million No Change1.8%1.4 $18.98 FHTX Short Interest - Frequently Asked Questions What is Foghorn Therapeutics' current short interest? Short interest is the volume of Foghorn Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,300,000 shares of FHTX short. 5.35% of Foghorn Therapeutics' shares are currently sold short. Learn More on Foghorn Therapeutics' current short interest. What is a good short interest ratio for Foghorn Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FHTX shares currently have a short interest ratio of 14.0. Learn More on Foghorn Therapeutics's short interest ratio. What is a good short interest percentage for Foghorn Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.35% of Foghorn Therapeutics' floating shares are currently sold short. Is Foghorn Therapeutics' short interest increasing or decreasing? Foghorn Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,300,000 shares, a decrease of 1.5% from the previous total of 1,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Foghorn Therapeutics' float size? Foghorn Therapeutics currently has issued a total of 42,590,000 shares. Some of Foghorn Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Foghorn Therapeutics currently has a public float of 24,320,000 shares. How does Foghorn Therapeutics' short interest compare to its competitors? 5.35% of Foghorn Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Foghorn Therapeutics: Inozyme Pharma, Inc. (6.46%), C4 Therapeutics, Inc. (16.48%), Liquidia Co. (10.28%), OPKO Health, Inc. (26.01%), Ironwood Pharmaceuticals, Inc. (14.52%), Tyra Biosciences, Inc. (7.69%), Ocular Therapeutix, Inc. (13.70%), ABIVAX Société Anonyme (0.12%), ARS Pharmaceuticals, Inc. (16.07%), Immunome, Inc. (4.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Foghorn Therapeutics stock? Short selling FHTX is an investing strategy that aims to generate trading profit from Foghorn Therapeutics as its price is falling. FHTX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Foghorn Therapeutics? A short squeeze for Foghorn Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FHTX, which in turn drives the price of the stock up even further. How often is Foghorn Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FHTX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Inozyme Pharma Short Interest Data C4 Therapeutics Short Interest Data Liquidia Short Interest Data OPKO Health Short Interest Data Ironwood Pharmaceuticals Short Interest Data Tyra Biosciences Short Interest Data Ocular Therapeutix Short Interest Data ABIVAX Société Anonyme Short Interest Data ARS Pharmaceuticals Short Interest Data Immunome Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FHTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.